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Objective: to estimate the rate and the significance of low
level viraemia in HIV positive patients registered in the
National Institute for Infectious Diseases “Prof. Dr. Matei
Balş”, Bucharest, Romania.
We retrospectively analysed the rate of HIV viral loads
(VL) <200 copies/mL in patients admitted in our institute
from 2011 to 2013. The patients with undetectable VLs in
2011 and low level VL in 2012 were selected and divided
into three groups, according to their HIV RNA (<40,
41-50 and 51-200 copies/mL, respectively). We evaluated
for each group the risk of virological failure (VL>200 and
>1000 copies/mL) over a 12 months period.
A low level VL was detected in 16.2% of the 3,916 evalu-
ated patients, the rate of HIV RNA of 51-200 copies/mL
being two times higher than the rate of a VL <50 copies/
mL. A number of 84 patients had a VL<200 copies/mL
after being HIV RNA undetectable. In these patients the
risk of virological failure over a 12 months period was not
correlated with the HIV VL group or the used antiretro-
viral treatment (protease inhibitors PI vs. non-PI contain-
ing regimen).
A low level viraemia is a rather common event in the
studied HIV patients. In previously undetectable patients
a HIV RNA <200 copies/mL is not associated with an
increased risk of virological failure in the next year.
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